Camille Samuels
VCPartner, Venrock
Venrock's first female partner, biotech focus
Menlo Park, CA$2M–$40M checks3 notable investments
SeedSeries ASeries B+
BioHealthcareConsumer
Background
Camille Samuels is a Partner at Venrock and the firm's first female partner, focusing on early-stage biotech, medical devices, and consumer health. She joined Venrock in 2014 after 12 years at Versant Ventures. At Versant, she seeded Kythera Biopharmaceuticals, which was acquired by Allergan for $2.1 billion. She holds a BA in Biology from Duke University and an MBA from Harvard Business School, where she graduated as a Baker Scholar.
Investment Thesis
Early-stage biotech and medical device companies leveraging novel biology to address unmet patient needs.
Investment Focus
Stages
SeedSeries ASeries B+
Typical check: $2M–$40M
Sectors
BioHealthcareConsumer
Based in: Menlo Park, CA (North America)
Notable Investments
Last updated: Jun 11, 2026